TY  - JOUR
AU  - López Zúñiga, Miguel Ángel
AU  - Moreno-Moral, Aida
AU  - Ocaña-Granados, Ana
AU  - Padilla-Moreno, Francisco Andrés
AU  - Castillo-Fernández, Alba María
AU  - Guillamón-Fernández, Dionisio
AU  - Ramírez-Sánchez, Carolina
AU  - Sanchez-Palop, María
AU  - Martínez-Colmenero, Justo
AU  - Pimentel-Villar, María Amparo
AU  - Blázquez-Roselló, Sara
AU  - Moreno-Sánchez, José Juan
AU  - López-Vílchez, María
AU  - Prior-Sánchez, Inmaculada
AU  - Jódar-Moreno, Rosario
AU  - López Ruz, Miguel Ángel
PY  - 2021
DO  - 10.1371/journal.pone.0243964
UR  - http://hdl.handle.net/10668/17063
T2  - PloS one
AB  - Test whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone or dexamethasone is associated with increased survival in COVID-19 patients at risk of hyper-inflammatory response. Provide some initial diagnostic criteria...
LA  - en
KW  - Adrenal Cortex Hormones
KW  - Adult
KW  - Aged
KW  - COVID-19
KW  - Cytokine Release Syndrome
KW  - Dexamethasone
KW  - Female
KW  - Hospitalization
KW  - Humans
KW  - Inflammation
KW  - Male
KW  - Methylprednisolone
KW  - Middle Aged
KW  - Prospective Studies
KW  - SARS-CoV-2
KW  - Spain
KW  - Survival Rate
KW  - COVID-19 Drug Treatment
TI  - High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.
TY  - research article
VL  - 16
ER  -